Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › BMRN
DEERFIELD MANAGEMENT COMPANY, L.P. position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 1,332,836 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q2 2026 13F filing — a position valued at US$76.3M, representing 0.96% of its reported portfolio and ranking #31 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed BMRN holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DEERFIELD MANAGEMENT COMPANY, L.P.'s BMRN position evolved
DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in BMRN in Q2 2024 at 9,832 shares (US$809K). The position peaked in Q2 2026 at 1,332,836 shares, worth US$76.3M. Across 4 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,332,836 shares valued at US$76.3M — an increase of 481,280 shares quarter over quarter.. Notable position changes include a 57% increase in Q2 2026 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 9.83K | $809.47K | New |
| Q3 2024 | 9.26K | $650.53K | Reduce |
| Q1 2026 | 851.56K | $48.10M | New |
| Q2 2026 | 1.33M | $76.26M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMRN and 13F data
BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 27 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMRN
- PRIMECAP MANAGEMENT CO/CA/ 14.19M sh · $811.96M · Q2 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.62M sh · $435.82M · Q2 2026
- Vestal Point Capital, LP 6.03M sh · $344.75M · Q2 2026
- Deep Track Capital, LP 3.31M sh · $189.25M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M sh · $108.89M · Q2 2026
More on DEERFIELD MANAGEMENT COMPANY, L.P.
FAQ
How long has DEERFIELD MANAGEMENT COMPANY, L.P. held BMRN?
DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed BMRN holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in BMRN?
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 1.33M shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $76.26M, representing 0.96% of its reported portfolio and ranking #31.
Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling BMRN?
In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. increased its position in BMRN. The position peaked in Q2 2026 at 1.33M shares.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.